Banner Image

Test Directory

Oxcarbazepine Metabolite

Test Summary

Oxcarbazepine (Trileptal) is an anti-convulsant used for treating generalized tonic-clonic and partial seizures. It can be administered alone or as an adjunct to other anti-convulsants. Clinically significant effects of oxcarbazepine are observed when plasma levels of its active metabolite, 10-OH-carbazepine, are between 15 and 35 ug/mL. Toxic symptoms may occur when plasma levels exceed 35 ug/mL. The therapeutic monitoring of oxcarbazepine and its active metabolite are important for achieving proper serum/plasma concentration to inhibit epileptic seizures and avoid adverse effects. The precise mechanism of the action by which oxcarbazepine and its active metabolite exert their antiseizure effect is unknown. However, in vitro electro-physiological studies indicate that they produce blockade of voltage-sensitive sodium channels, resulting in the stabilization of hyperexcited neural membranes, inhibition of repetitive neuronal firing, and diminution of propagation of synaptic impulses. These are important in prevention of seizure spread in the brain. In addition, the increased potassium conduction and calcium channel activities may contribute to the antiseizure treatment effects. After oral administration, oxcarbazepine is readily absorbed in the body, followed by rapid and almost complete metabolization to 10-OH-carbazepine, active metabolite. The half-life of oxcarbazepine is only 1 to 2.5 hours, while that of 10-OH-carbazepine is 11 to 15 hours. The protein binding of oxcarbazepine is about 67%, whereas that of the metabolite is about 38%. The clearance of oxcarbazepine and its active metabolite from the body is mainly through ketone reduction and O-site conjugation with glucuronic acid rather than oxidative processes via cytochrome P450 system. More than 95% of the treatment dosage is excreted by the kidneys. Fecal excretion only accounts for less than 4%.

Aliases

  • Trileptal

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1 mL serum collected in a red-top tube (no gel)

Minimum Volume

0.25 mL

Instructions

N/A

Patient Preparation

N/A

Storage

Plastic screw-cap vial

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

  • Room temperature: 72 hours
  • Refrigerated: 14 days
  • Frozen: 60 days

Limitations

N/A

Other Acceptable Specimens

Plasma collected in: EDTA (lavender-top) tube

Unacceptable Specimens

Serum Separator Tube (SST®)

Order Code

OXCARB

EPIC (Premier) Code

LAB3864

Includes

10-Hydroxycarbazepine

CPT Code

  • 80183

Billing Code

  • 670376

CPT Statement

Methodology

Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly VA, 20153

Department

Reference Testing

Reference Range

10-Hydroxycarbazepine 8.0-35.0 mcg/mL

Setup Schedule / Expected Turnaround Time

Monday - Saturday evening; Report available: 1 - 3 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

1 mL serum collected in a red-top tube (no gel)

Minimum Volume

0.25 mL

Instructions

N/A

Patient Preparation

N/A

Storage

Plastic screw-cap vial

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

  • Room temperature: 72 hours
  • Refrigerated: 14 days
  • Frozen: 60 days

Limitations

N/A

Other Acceptable Specimens

Plasma collected in: EDTA (lavender-top) tube

Unacceptable Specimens

Serum Separator Tube (SST®)

Billing

CPT Code

  • 80183

Billing Code

  • 670376

CPT Statement

Result Information

Methodology

Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)

Testing Laboratory

N/A

Reference Range

10-Hydroxycarbazepine 8.0-35.0 mcg/mL

Setup Schedule / Expected Turnaround Time

Monday - Saturday evening; Report available: 1 - 3 days